ID   TU-KATO-III
AC   CVCL_VL11
SY   TU-kato-III; Tumorigenic-KATO-III
DR   BTO; BTO:0006122
DR   Wikidata; Q98133684
RX   PubMed=17505008;
CC   Population: Japanese.
CC   Characteristics: Has a high tumorigenic potential. Established after seven tumor passages of KATO-III in nude mice.
CC   Sequence variation: Gene deletion; HGNC; 11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 10
//
RX   PubMed=17505008; DOI=10.1158/1078-0432.CCR-06-2743;
RA   Takeda M., Arao T., Yokote H., Komatsu T., Yanagihara K., Sasaki H.,
RA   Yamada Y., Tamura T., Fukuoka K., Kimura H., Saijo N., Nishio K.;
RT   "AZD2171 shows potent antitumor activity against gastric cancer
RT   over-expressing fibroblast growth factor receptor 2/keratinocyte
RT   growth factor receptor.";
RL   Clin. Cancer Res. 13:3051-3057(2007).
//